Gowling WLG has been shortlisted in four categories at the LMG Life Sciences EMEA Awards 2026, which recognise the region's most distinguished practitioners and firms for their exemplary work in life sciences legal practice over the past year.
The firm has been named a finalist for:
- International Firm of the Year
- Patent Litigation Firm of the Year: Biotech
- Licensing & Collaboration Lawyer of the Year – Patrick Duxbury
- Patent Litigator of the Year: Biotech – Huw Evans
These shortlistings reflect the strength and depth of the firm's international Life Sciences practice, spanning complex cross‑border litigation, strategic licensing and collaboration arrangements, and specialist sector expertise across biotech, pharmaceuticals and medical technologies.
Patrick Duxbury's nomination for Licensing & Collaboration Lawyer of the Year recognises his market‑leading work advising on high‑value transactions and partnerships across the global life sciences ecosystem. Huw Evans' shortlisting for Patent Litigator of the Year: Biotech highlights his expertise in managing complex, multi‑jurisdictional disputes involving cutting‑edge scientific and technological issues.
The LMG Life Sciences EMEA Awards celebrate the most impactful cases, deals and legal work across the life sciences sector, following extensive research and submission review. The programme includes Practice Area Awards recognising excellence across key areas of life sciences legal work, and Lawyer of the Year Awards celebrating partners demonstrating outstanding professional achievement and thought leadership during the past year. The winners will be announced at an awards gala event in London on Thursday 4 June 2026.
Commenting on the shortlistings, Patrick Duxbury said: "These nominations are a fantastic recognition of the strength and in-depth expertise of our international Life Sciences team, and the complex, innovative work they are delivering for clients. The past year has seen many changes impacting the sector and supportive moves to encourage growth. We're working closely with a wide range of business across the life sciences ecosystem and are proud to support them in pushing forward with their strategic priorities."
Gowling WLG's international Life Sciences team advises clients across the full product lifecycle, offering integrated expertise in intellectual property, regulatory matters, commercial transactions, corporate strategy and dispute resolution.